Cerulean Pharma reported $-8399000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Agile Therapeutics AGRX:US $ -11.77M 11.59M
Arrowhead Research ARWR:US $ 44.37M 107.24M
Bayer BAYN:GR € 3291M 2130M
Biocept BIOC:US $ -2.77M 0.2M
Brainstorm Cell Therapeutics BCLI:US $ -5.36M 0.83M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Immunogen IMGN:US $ -24.14M 13.03M
Johnson & Johnson JNJ:US $ 5149M 413M
Macrogenics MGNX:US $ -66.44M 8.42M
Merk MRK:US $ 4310M 552M
Nektar Therapeutics NKTR:US $ -90.39M 55.25M
Perrigo Ordinary Shares PRGO:US $ -2.4M 12M
Pfizer PFE:US $ 7863M 4470M
Seattle Genetics SGEN:US $ -136.49M 38.13M
YTE INCY:US $ 37.99M 525.86M